Delivery Technology Solutions, Inc. (Pinksheets:DTSL), the leader in delivery management technology, has completed participation at one of the largest restaurant franchisee conventions, held July 22-25, 2010. Its UDS division attended the convention by invitation of the leading franchisor, and was able to showcase its large corporate catering and event management delivery technology platform to many of the thousands of convention attendees, and a range of other potential partners in the industry and associated industries.
�This was our first opportunity to interact face-to-face on a large scale with franchisees from all across American, Canadian, European, Middle Eastern and Asian markets,� said Ryan Coblin, CEO. �We could shake their hands, explain the opportunities our solutions offer, answer their questions and sign them up for follow-up contacts.�
Over the three-day event the company was successful in signing up franchisees that own thousands of locations, and multiple-territory development agents who represent thousands more. These signed prospects will be contacted by the franchisor and UDS to offer them optional programs to expand their customer base, increase sales and build new profits for their restaurants. Qualified franchisees are enrolled in the optional programs, and then UDS proprietary software is implemented at their unit, so orders may be received from the UDS Call Center and Online Ordering technology.
he UDS Division is already planning for a larger role in next year’s convention, due to the volume of responses expressed by this year’s attendees, and the warm welcome that was received within the vendor community. While currently in expansion of its in-house sales and marketing department, UDS is expecting to implement up to 1,500 locations before the end of 2010, and many more in 2011.
Champion Industries, Inc. (Nasdaq: CHMP) reported results for the third quarter of 2010 of a loss of $(571,000) or $(0.06) per share compared to a loss of $(307,000) or $(0.03) per share for the same period in 2009. The results were reflective of restructuring related charges of approximately $1.6 million, or $1.0 million after tax, or $0.10 per share on a basic and diluted basis. On a pro forma basis, adjusted for the restructuring charge, the Company would have reported net income of approximately $0.4 million or $0.04 per share on a basic and diluted basis for the three months ended July 31, 2010, compared to a pro forma loss of $(0.2) million or $(0.02) per share on a basic and diluted basis for the three months ended July 31, 2009.
Net loss for the nine months ended July 31, 2010 was $(450,000) or $(0.05) per share on a basic and diluted basis. This compares to a loss of $(646,000) or $(0.06) per share on a basic and diluted basis for the same period in 2009. On a pro forma basis, adjusted for the restructuring charge, the Company would have reported net income of approximately $0.6 million or $0.06 per share on a basic and diluted basis for the nine months ended July 31, 2010, compared to a pro forma loss of $(0.5) million or $(0.05) per share on a basic and diluted basis for the nine months ended July 31, 2009.
Marshall T. Reynolds, Chairman of the Board and Chief Executive Officer of Champion, said, “Our year to date and third quarter income reflected a strong improvement over the prior year on a pro forma basis adjusting for the restructuring related charges. Our second quarter and year to date results were negatively impacted by costs related to the successful defense of a legal action and would have been even stronger without this event. Our third quarter was focused on continued implementation of our plant rationalization plan and a continued review of our operating cost structure.”
Champion is a commercial printer, business forms manufacturer and office products and office furniture supplier in regional markets east of the Mississippi. Champion also publishes The Herald-Dispatch daily newspaper in Huntington, WV with a total daily and Sunday circulation of approximately 25,000 and 30,000, respectively.
Changyou.com Limited (Nasdaq: CYOU), a leading online game developer and operator in China, began open-beta testing of Immortal Faith, the Company’s first 2D martial arts massively multi-player online role-playing game (“MMORPG”), on September 9, 2010.
Immortal Faith is a game licensed from a local game studio in China. Set against a backdrop of a number of ancient Chinese myths and folk tales, the game allows players to battle demons and assist deities in the conquest of various fairy kingdoms found in Chinese mythology. By participating in the specially designed fighting modes and utilizing the game’s featured dynamic fighting moves, the game lets users experience the life journey of becoming immortal.
Mr. Dewen Chen, President and Chief Operating Officer of Changyou, commented, “The open beta launch of Immortal Faith brings Changyou into the 2D mythical MMORPG segment, and furthers our product diversification efforts. Packed with attractive graphics showcasing different cultural elements from ancient China, the game contains many creative forms of combat aimed at attracting a new group of players to further expand our user base.”
Charles River Laboratories International, Inc. (NYSE: CRL) has implemented an accelerated stock repurchase (ASR) program to repurchase $300 million of common stock, as part of its previously announced authorization from its Board of Directors to repurchase up to $500 million of common stock. The new ASR program will enable the Company to facilitate, on a more timely and cost efficient basis, the repurchase of a substantial number of its shares pursuant to that stock repurchase authorization.
Under the ASR program entered into with Morgan Stanley & Co. Incorporated, the Company will receive an initial delivery of 6.0 million shares. The actual number of shares that Charles River repurchases under the ASR program will be determined based on a discount to the daily volume-weighted average price (VWAP) of its common stock over the course of a calculation period, which may extend approximately six months or conclude earlier at Morgan Stanley�s option. The Company intends to fund the repurchases through cash on hand and available liquidity, including its $750 million credit facility.
Accelerating Drug Development. Exactly. Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our approximately 8,000 employees worldwide are focused on providing clients with exactly what they need to improve and expedite the discovery, development through first-in-human evaluation, and safe manufacture of new therapies for the patients who need them.